FDA Sends Out 10 Warning Letters to Dietary Supplement Manufacturers | Eye on FDA:
"10 Count ‘em 10.
That is how many Warning Letters the agency sent out last Friday to manufacturers and distributors of dietary supplements. The specific focus of the letters was products that were being marketed containing dimethylamylamine, also known as DMAA, sold as a “natural stimulant”.
The list contains 10 different manufacturers covering 15 separate products.
The specific violation cited in the letters was that current law states that when supplements contain dietary ingredients not marketed before October 15, 1994, manufacturers must submit the new ingredient for use as a New Dietary Ingredient, notifying FDA of evidence that supports a conclusion that use is safe. The agency said in the letters that this requirement had not been met."
'via Blog this'
Monday, April 30, 2012
FDA Sends Out 10 Warning Letters to Dietary Supplement Manufacturers
Saturday, April 28, 2012
Drug Disposal - National Take-Back Initiative
Drug Disposal - National Take-Back Initiative:
"April 28, 2012 - 10:00 AM - 2:00 PM
The Drug Enforcement Administration (DEA) has scheduled another National Prescription Drug Take-Back Day which will take place on Saturday, April 28, 2012, from 10:00 a.m. to 2:00 p.m. This is a great opportunity for those who missed the previous events, or who have subsequently accumulated unwanted, unused prescription drugs, to safely dispose of those medications.
Americans that participated in the DEA’s third National Prescription Drug Take-Back Day on October 29, 2011, turned in more than 377,086 pounds (188.5 tons) of unwanted or expired medications for safe and proper disposal at the 5,327 take-back sites that were available in all 50 states and U.S. territories. When the results of the three prior Take-Back Days are combined, the DEA, and its state, local, and tribal law-enforcement and community partners have removed 995,185 pounds (498.5 tons) of medication from circulation in the past 13 months."
'via Blog this'
Friday, April 27, 2012
Press Announcements - FDA approves Stendra for erectile dysfunction
Updated December 30, 2019
The link in the original post broke.
You might also be interested in:
FDA Approves New Erectile Dysfunction Drug Stendra - WebMD
- - - original post follows below - - -
Do we really need another one?! And what about the name!?
Press Announcements - FDA approves Stendra for erectile dysfunction:
"The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.
Erectile dysfunction is when a man has trouble getting or keeping an erection. An estimated 30 million men in the United States are affected by erectile dysfunction.
Stendra is a pill that patients take on an as-needed basis 30 minutes before sexual activity. Doctors should prescribe the lowest dose of Stendra that provides benefit."
'via Blog this'
FDA ‘Aghast’ at Lack of cGMP, AER Compliance by Supplement Manufacturers
- People also search for FDA GMP online training programs and courses taught by SkillsPlus International Inc.
"The US Food and Drug Administration’s (FDA) top dietary supplement regulator said at an industry conference meeting he is “aghast at the degree of non-compliance” when it comes to current good manufacturing practices (cGMPs) and adverse event reporting (AER) in the industry, reports Nutra Ingredients USA.
Speaking 25 April to a meeting convened by the Natural Products Association, Daniel Fabricant, director of FDA’s Division of Dietary Supplement Programs, said the industry has been exhibiting a level of non-compliance he says is troubling."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store
Related articles
- Deviation Investigation Reports - Live onsite cGMP & QSR training class (skillsplusinfo.blogspot.com)
- cGMP/QSR Trainer Certification - Public Seminar - Oct 22-26, 2012 (skillsplusinfo.blogspot.com)
Tuesday, April 24, 2012
FDA Global Initiative
Updated June 30, 2024
- Report: Global Engagement (PDF - 5 MB)
FDA Global Initiative:
"Global production of FDA-regulated products has quadrupled over the last decade and continues to grow. Today, FDA-regulated products originate from more than 150 countries, 130,000 importers and 300,000 foreign facilities.
Almost 40 percent of the fruits and nuts and 85 percent of the seafood consumed in America comes from abroad. Similarly, more than 80 percent of the active pharmaceutical ingredients used to make medicines are imported. The growth in imports has been rapid and promises to accelerate.
Globalization has fundamentally altered the economic and security landscape and demands a major change in the way FDA fulfills its mission. Over the next decade, FDA will transform from a predominantly domestically-focused agency operating in a globalized economy to a modern public health regulatory agency fully prepared for a complex globalized regulatory environment."
'via Blog this'
Return Home: The Health, Drug, Prescription, and GMP Supersite Blog
SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store